2026-04-29T02:37:36Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/225882024-11-28T20:25:25Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Chaplin, Alice author Carpene, Christian author Mercader, Josep author 2018-11 Resveratrol is a polyphenol which has been shown to have beneficial effects on metabolic syndrome-related alterations in experimental animals, including glucose and lipid homeostasis improvement and a reduction in fat mass, blood pressure, low-grade inflammation, and oxidative stress. Clinical trials have been carried out to address its potential; however, results are still inconclusive. Even though resveratrol is partly metabolized by gut microbiota, the relevance of this forgotten organ had not been widely considered. However, in the past few years, data has emerged suggesting that the therapeutic potential of this compound may be due to its interaction with gut microbiota, reporting changes in bacterial composition associated with beneficial metabolic outcomes. Even though data is still scarce and for the most part observational, it is promising nevertheless, suggesting that resveratrol supplementation could be a useful tool for the treatment of metabolic syndrome and its associated conditions. Chaplin A, Carpene C, Mercader J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients. 2018 Nov;10(11):1651. http://hdl.handle.net/20.500.13003/9044 https://hdl.handle.net/20.500.12105/22588 30400297 10.3390/nu10111651 2072-6643 Nutrients 2-s2.0-85056144665 451547700089 L624752478 Resveratrol Gut microbiota Metabolic syndrome Resveratrol, Metabolic Syndrome, and Gut Microbiota